Published in Biochem Pharmacol on February 04, 2012
Gene expression patterns unveil a new level of molecular heterogeneity in colorectal cancer. J Pathol (2013) 1.71
The Concise Guide to PHARMACOLOGY 2013/14: nuclear hormone receptors. Br J Pharmacol (2013) 1.70
Mechanisms of activation of the transcription factor Nrf2 by redox stressors, nutrient cues, and energy status and the pathways through which it attenuates degenerative disease. Free Radic Biol Med (2015) 1.17
Sucralose, a synthetic organochlorine sweetener: overview of biological issues. J Toxicol Environ Health B Crit Rev (2013) 1.06
Pregnane xenobiotic receptor in cancer pathogenesis and therapeutic response. Cancer Lett (2012) 1.06
EPMA position paper in cancer: current overview and future perspectives. EPMA J (2015) 1.04
PXR antagonists and implication in drug metabolism. Drug Metab Rev (2013) 1.03
Chrysin ameliorates chemically induced colitis in the mouse through modulation of a PXR/NF-κB signaling pathway. J Pharmacol Exp Ther (2013) 1.02
The effect of environmental chemicals on the tumor microenvironment. Carcinogenesis (2015) 0.91
miR-137 regulates the constitutive androstane receptor and modulates doxorubicin sensitivity in parental and doxorubicin-resistant neuroblastoma cells. Oncogene (2013) 0.90
PXR and CAR single nucleotide polymorphisms influence plasma efavirenz levels in South African HIV/AIDS patients. BMC Med Genet (2012) 0.89
Grape seed procyanidin reversal of p-glycoprotein associated multi-drug resistance via down-regulation of NF-κB and MAPK/ERK mediated YB-1 activity in A2780/T cells. PLoS One (2013) 0.89
Diindolylmethane, a naturally occurring compound, induces CYP3A4 and MDR1 gene expression by activating human PXR. Toxicol Lett (2014) 0.82
Intracellular targeted co-delivery of shMDR1 and gefitinib with chitosan nanoparticles for overcoming multidrug resistance. Int J Nanomedicine (2015) 0.81
Tissue-specific regulation of pregnane X receptor in cancer development and therapy. Cell Biosci (2014) 0.81
Bitter melon extracts enhance the activity of chemotherapeutic agents through the modulation of multiple drug resistance. J Pharm Sci (2013) 0.80
Drug metabolism and clearance system in tumor cells of patients with multiple myeloma. Oncotarget (2015) 0.80
HDAC inhibitor-induced drug resistance involving ATP-binding cassette transporters (Review). Oncol Lett (2014) 0.79
Constitutive androstane receptor ligands modulate the anti-tumor efficacy of paclitaxel in non-small cell lung cancer cells. PLoS One (2014) 0.79
Role of pregnane X receptor in chemotherapeutic treatment. Cancer Chemother Pharmacol (2014) 0.79
Chalinulasterol, a chlorinated steroid disulfate from the Caribbean sponge Chalinula molitba. Evaluation of its role as PXR receptor modulator. Mar Drugs (2012) 0.79
Co-expression of pregnane X receptor and ATP-binding cassette sub-family B member 1 in peripheral blood: A prospective indicator for drug resistance prediction in non-small cell lung cancer. Oncol Lett (2016) 0.79
Solomonsterol A, a marine pregnane-X-receptor agonist, attenuates inflammation and immune dysfunction in a mouse model of arthritis. Mar Drugs (2013) 0.78
Thiazide-like diuretic drug metolazone activates human pregnane X receptor to induce cytochrome 3A4 and multidrug-resistance protein 1. Biochem Pharmacol (2014) 0.77
Lipid-sensors, enigmatic-orphan and orphan nuclear receptors as therapeutic targets in breast-cancer. Oncotarget (2016) 0.77
Expression of NR1I3 in mouse lung tumors induced by the tobacco-specific nitrosamine 4-(methylnitrosamino)-4-(3-pyridyl)-1-butanone. Braz J Med Biol Res (2015) 0.77
Biology of PXR: role in drug-hormone interactions. EXCLI J (2014) 0.76
Zebrafish vitamin K epoxide reductases: expression in vivo, along extracellular matrix mineralization and under phylloquinone and warfarin in vitro exposure. Fish Physiol Biochem (2015) 0.76
The pregnane X receptor down-regulates organic cation transporter 1 (SLC22A1) in human hepatocytes by competing for ("squelching") SRC-1 coactivator. Br J Pharmacol (2016) 0.75
Hematological and liver toxicity of anti-tuberculosis drugs. Electron Physician (2016) 0.75
Collagen density regulates xenobiotic and hypoxic response of mammary epithelial cells. Environ Toxicol Pharmacol (2014) 0.75
A novel mathematical model describing adaptive cellular drug metabolism and toxicity in the chemoimmune system. PLoS One (2015) 0.75
Access Path to the Ligand Binding Pocket May Play a Role in Xenobiotics Selection by AhR. PLoS One (2016) 0.75
Pregnane X receptor is associated with unfavorable survival and induces chemotherapeutic resistance by transcriptional activating multidrug resistance-related protein 3 in colorectal cancer. Mol Cancer (2017) 0.75
Suppression of carboxylesterases by imatinib mediated by the down-regulation of pregnane X receptor. Br J Pharmacol (2017) 0.75
Upregulation of miR-142-3p Improves Drug Sensitivity of Acute Myelogenous Leukemia through Reducing P-Glycoprotein and Repressing Autophagy by Targeting HMGB1. Transl Oncol (2017) 0.75
A Molecular Aspect in the Regulation of Drug Metabolism: Does PXR-Induced Enzyme Expression Always Lead to Functional Changes in Drug Metabolism? Curr Pharmacol Rep (2016) 0.75
Differential effects of the enantiomers of tamsulosin and tolterodine on P-glycoprotein and cytochrome P450 3A4. Naunyn Schmiedebergs Arch Pharmacol (2016) 0.75
Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Adv Drug Deliv Rev (2001) 36.00
Cancer statistics, 2005. CA Cancer J Clin (2005) 25.65
The nuclear receptor superfamily: the second decade. Cell (1995) 24.99
A receptor-mediated pathway for cholesterol homeostasis. Science (1986) 19.28
Regulation of the mevalonate pathway. Nature (1990) 18.25
The RXR heterodimers and orphan receptors. Cell (1995) 12.33
The coregulator exchange in transcriptional functions of nuclear receptors. Genes Dev (2000) 11.65
Targeting multidrug resistance in cancer. Nat Rev Drug Discov (2006) 10.55
Glutathione transferases. Annu Rev Pharmacol Toxicol (2005) 9.67
Differential expression of peroxisome proliferator-activated receptors (PPARs): tissue distribution of PPAR-alpha, -beta, and -gamma in the adult rat. Endocrinology (1996) 7.92
Bile acids: natural ligands for an orphan nuclear receptor. Science (1999) 7.18
A regulatory cascade of the nuclear receptors FXR, SHP-1, and LRH-1 represses bile acid biosynthesis. Mol Cell (2000) 7.18
Targeted disruption of the alpha isoform of the peroxisome proliferator-activated receptor gene in mice results in abolishment of the pleiotropic effects of peroxisome proliferators. Mol Cell Biol (1995) 7.12
Cholesterol and bile acid metabolism are impaired in mice lacking the nuclear oxysterol receptor LXR alpha. Cell (1998) 6.70
Biochemical, cellular, and pharmacological aspects of the multidrug transporter. Annu Rev Pharmacol Toxicol (1999) 6.62
A multidrug resistance transporter from human MCF-7 breast cancer cells. Proc Natl Acad Sci U S A (1998) 6.47
An orphan nuclear receptor activated by pregnanes defines a novel steroid signaling pathway. Cell (1998) 5.97
Transcriptional regulation of gene expression during adipocyte differentiation. Annu Rev Biochem (1995) 5.75
Crystal structure of the ligand-binding domain of the human nuclear receptor RXR-alpha. Nature (1995) 5.40
Use of prescription and over-the-counter medications and dietary supplements among older adults in the United States. JAMA (2008) 5.27
LXR, a nuclear receptor that defines a distinct retinoid response pathway. Genes Dev (1995) 4.93
The P450 superfamily: update on new sequences, gene mapping, accession numbers, early trivial names of enzymes, and nomenclature. DNA Cell Biol (1993) 4.92
Human UDP-glucuronosyltransferases: metabolism, expression, and disease. Annu Rev Pharmacol Toxicol (2000) 4.87
Activation of the nuclear receptor LXR by oxysterols defines a new hormone response pathway. J Biol Chem (1997) 4.81
The PAS superfamily: sensors of environmental and developmental signals. Annu Rev Pharmacol Toxicol (2000) 4.79
The human orphan nuclear receptor PXR is activated by compounds that regulate CYP3A4 gene expression and cause drug interactions. J Clin Invest (1998) 4.76
Fatty acids, eicosanoids, and hypolipidemic agents identified as ligands of peroxisome proliferator-activated receptors by coactivator-dependent receptor ligand assay. Mol Endocrinol (1997) 4.71
A steroid receptor coactivator, SRA, functions as an RNA and is present in an SRC-1 complex. Cell (1999) 4.65
Anatomical profiling of nuclear receptor expression reveals a hierarchical transcriptional network. Cell (2006) 4.64
The nuclear receptor PXR is a lithocholic acid sensor that protects against liver toxicity. Proc Natl Acad Sci U S A (2001) 4.58
SXR, a novel steroid and xenobiotic-sensing nuclear receptor. Genes Dev (1998) 4.19
Cytochrome P-450 3A4: regulation and role in drug metabolism. Annu Rev Pharmacol Toxicol (1999) 3.63
The nuclear orphan receptor CAR-retinoid X receptor heterodimer activates the phenobarbital-responsive enhancer module of the CYP2B gene. Mol Cell Biol (1998) 3.60
The orphan nuclear receptor SXR coordinately regulates drug metabolism and efflux. Nat Med (2001) 3.45
Humanized xenobiotic response in mice expressing nuclear receptor SXR. Nature (2000) 3.41
Orphan nuclear receptors: from gene to function. Endocr Rev (1999) 3.29
The human nuclear xenobiotic receptor PXR: structural determinants of directed promiscuity. Science (2001) 3.27
Controlling nuclear receptors: the circular logic of cofactor cycles. Nat Rev Mol Cell Biol (2005) 3.25
Identification of a human nuclear receptor defines a new signaling pathway for CYP3A induction. Proc Natl Acad Sci U S A (1998) 3.24
Androstane metabolites bind to and deactivate the nuclear receptor CAR-beta. Nature (1998) 3.23
Orphan nuclear receptors constitutive androstane receptor and pregnane X receptor share xenobiotic and steroid ligands. J Biol Chem (2000) 3.23
The repressed nuclear receptor CAR responds to phenobarbital in activating the human CYP2B6 gene. J Biol Chem (1999) 3.14
Nomenclature update for the mammalian UDP glycosyltransferase (UGT) gene superfamily. Pharmacogenet Genomics (2005) 2.98
Functional consequences of cysteine modification in the ligand binding sites of peroxisome proliferator activated receptors by GW9662. Biochemistry (2002) 2.97
Nuclear pregnane x receptor and constitutive androstane receptor regulate overlapping but distinct sets of genes involved in xenobiotic detoxification. Mol Pharmacol (2002) 2.94
The role of DNA mismatch repair in platinum drug resistance. Cancer Res (1996) 2.88
A new orphan member of the nuclear hormone receptor superfamily that interacts with a subset of retinoic acid response elements. Mol Cell Biol (1994) 2.85
The pregnane X receptor: a promiscuous xenobiotic receptor that has diverged during evolution. Mol Endocrinol (2000) 2.74
Association of the Ah receptor with the 90-kDa heat shock protein. J Biol Chem (1988) 2.70
Regulation of multidrug resistance-associated protein 2 (ABCC2) by the nuclear receptors pregnane X receptor, farnesoid X-activated receptor, and constitutive androstane receptor. J Biol Chem (2001) 2.70
Modulation of acetaminophen-induced hepatotoxicity by the xenobiotic receptor CAR. Science (2002) 2.66
St. John's wort induces hepatic drug metabolism through activation of the pregnane X receptor. Proc Natl Acad Sci U S A (2000) 2.64
Clinical pharmacokinetics and metabolism of irinotecan (CPT-11). Clin Cancer Res (2001) 2.64
Nuclear receptor response elements mediate induction of intestinal MDR1 by rifampin. J Biol Chem (2001) 2.62
Multiple drug resistance in cancer revisited: the cancer stem cell hypothesis. J Clin Pharmacol (2005) 2.52
Diverse roles of the nuclear orphan receptor CAR in regulating hepatic genes in response to phenobarbital. Mol Pharmacol (2002) 2.49
Control of steroid, heme, and carcinogen metabolism by nuclear pregnane X receptor and constitutive androstane receptor. Proc Natl Acad Sci U S A (2003) 2.46
Update: clinically significant cytochrome P-450 drug interactions. Pharmacotherapy (1998) 2.43
Apoptosis defects and chemotherapy resistance: molecular interaction maps and networks. Oncogene (2004) 2.36
Identification of a novel human constitutive androstane receptor (CAR) agonist and its use in the identification of CAR target genes. J Biol Chem (2003) 2.28
The xenobiotic compound 1,4-bis[2-(3,5-dichloropyridyloxy)]benzene is an agonist ligand for the nuclear receptor CAR. Mol Cell Biol (2000) 2.25
Relative activation of human pregnane X receptor versus constitutive androstane receptor defines distinct classes of CYP2B6 and CYP3A4 inducers. J Pharmacol Exp Ther (2006) 2.23
Enhanced chemosensitivity to CPT-11 with proteasome inhibitor PS-341: implications for systemic nuclear factor-kappaB inhibition. Cancer Res (2001) 2.18
Highly chlorinated PCBs inhibit the human xenobiotic response mediated by the steroid and xenobiotic receptor (SXR). Environ Health Perspect (2004) 2.16
Effects of St. John's wort on irinotecan metabolism. J Natl Cancer Inst (2002) 2.16
Reciprocal activation of xenobiotic response genes by nuclear receptors SXR/PXR and CAR. Genes Dev (2000) 2.15
Increasing the complexity of coactivation in nuclear receptor signaling. Cell (1999) 2.09
PXR, CAR and drug metabolism. Nat Rev Drug Discov (2002) 2.06
Local recurrence in head and neck cancer: relationship to radiation resistance and signal transduction. Clin Cancer Res (2002) 2.05
Complementary roles of farnesoid X receptor, pregnane X receptor, and constitutive androstane receptor in protection against bile acid toxicity. J Biol Chem (2003) 2.04
Aryl hydrocarbon receptor-mediated signal transduction. Crit Rev Toxicol (1997) 2.00
Orphan nuclear receptors--new ligands and new possibilities. Genes Dev (1998) 1.98
UDP-glucuronosyltransferases. Curr Drug Metab (2000) 1.94
Phase II study of low-dose decitabine in patients with chronic myelogenous leukemia resistant to imatinib mesylate. J Clin Oncol (2005) 1.93
Role of the constitutive androstane receptor in xenobiotic-induced thyroid hormone metabolism. Endocrinology (2004) 1.89
Hypoxia and anemia: factors in decreased sensitivity to radiation therapy and chemotherapy? Oncologist (2004) 1.88
Hepatitis B virus X-associated protein 2 is a subunit of the unliganded aryl hydrocarbon receptor core complex and exhibits transcriptional enhancer activity. Mol Cell Biol (1998) 1.86
Herb-drug interactions: review and assessment of report reliability. Br J Clin Pharmacol (2001) 1.85
Complementary stimulation of hepatobiliary transport and detoxification systems by rifampicin and ursodeoxycholic acid in humans. Gastroenterology (2005) 1.84
Phenobarbital response elements of cytochrome P450 genes and nuclear receptors. Annu Rev Pharmacol Toxicol (2001) 1.83
Structure, function and regulation of carboxylesterases. Chem Biol Interact (2006) 1.80
The phenobarbital response enhancer module in the human bilirubin UDP-glucuronosyltransferase UGT1A1 gene and regulation by the nuclear receptor CAR. Hepatology (2001) 1.79
Cancer stem cell characteristics in retinoblastoma. Mol Vis (2005) 1.77
Regulation of cytochrome P450 (CYP) genes by nuclear receptors. Biochem J (2000) 1.74
Coordinate regulation of xenobiotic and bile acid homeostasis by pregnane X receptor. Drug Metab Dispos (2001) 1.70
Evidence that the co-chaperone p23 regulates ligand responsiveness of the dioxin (Aryl hydrocarbon) receptor. J Biol Chem (1999) 1.69
Disrupted bile acid homeostasis reveals an unexpected interaction among nuclear hormone receptors, transporters, and cytochrome P450. J Biol Chem (2001) 1.67
The nuclear receptor CAR is a regulator of thyroid hormone metabolism during caloric restriction. J Biol Chem (2004) 1.65
Regulation of a xenobiotic sulfonation cascade by nuclear pregnane X receptor (PXR). Proc Natl Acad Sci U S A (2002) 1.65
Genetic profiling defines the xenobiotic gene network controlled by the nuclear receptor pregnane X receptor. Mol Endocrinol (2003) 1.61
Induction of Mrp3 and Mrp4 transporters during acetaminophen hepatotoxicity is dependent on Nrf2. Toxicol Appl Pharmacol (2007) 1.60
Orphan nuclear receptors: the exotics of xenobiotics. J Biol Chem (2001) 1.60
Role of orphan nuclear receptors in the regulation of drug-metabolising enzymes. Clin Pharmacokinet (2003) 1.60
A comparative study of p53 gene mutations, protein accumulation, and response to cisplatin-based chemotherapy in advanced ovarian carcinoma. Cancer Res (1996) 1.60
A novel constitutive androstane receptor-mediated and CYP3A-independent pathway of bile acid detoxification. Mol Pharmacol (2004) 1.59
Specific and overlapping functions of the nuclear hormone receptors CAR and PXR in xenobiotic response. Pharmacogenomics J (2002) 1.58
Coactivator binding promotes the specific interaction between ligand and the pregnane X receptor. J Mol Biol (2003) 1.57
Nuclear receptors and the regulation of drug-metabolizing enzymes and drug transporters: implications for interindividual variability in response to drugs. J Clin Pharmacol (2007) 1.56
Structural disorder in the complex of human pregnane X receptor and the macrolide antibiotic rifampicin. Mol Endocrinol (2005) 1.55
Guidelines for the use and interpretation of assays for monitoring autophagy. Autophagy (2012) 20.08
MicroRNA-21 targets tumor suppressor genes in invasion and metastasis. Cell Res (2008) 7.53
Eltrombopag and improved hematopoiesis in refractory aplastic anemia. N Engl J Med (2012) 3.93
Marked loss of myelinated nerve fibers in the human brain with age. J Comp Neurol (2003) 2.94
Sorafenib enhances pemetrexed cytotoxicity through an autophagy-dependent mechanism in cancer cells. Cancer Res (2011) 2.13
Mechanistic logic underlying the axonal transport of cytosolic proteins. Neuron (2011) 2.00
A pathologic cascade leading to synaptic dysfunction in alpha-synuclein-induced neurodegeneration. J Neurosci (2010) 1.80
Phosphine-triggered synthesis of functionalized cyclic compounds. Chem Soc Rev (2008) 1.80
Cyclooxygenases, prostanoids, and tumor progression. Cancer Metastasis Rev (2007) 1.72
Structure and chemistry of the p300/CBP and Rtt109 histone acetyltransferases: implications for histone acetyltransferase evolution and function. Curr Opin Struct Biol (2008) 1.72
Influence of affinity and antigen internalization on the uptake and penetration of Anti-HER2 antibodies in solid tumors. Cancer Res (2011) 1.62
Lipoxygenase metabolism: roles in tumor progression and survival. Cancer Metastasis Rev (2007) 1.57
Reliable, verifiable and efficient monitoring of biodiversity via metabarcoding. Ecol Lett (2013) 1.56
Estrogen increases the number of spinophilin-immunoreactive spines in the hippocampus of young and aged female rhesus monkeys. J Comp Neurol (2003) 1.49
A genome-wide association study identifies GRK5 and RASGRP1 as type 2 diabetes loci in Chinese Hans. Diabetes (2012) 1.47
Long-term clinical efficacy and safety of adding cilostazol to dual antiplatelet therapy for patients undergoing PCI: a meta-analysis of randomized trials with adjusted indirect comparisons. Curr Med Res Opin (2013) 1.44
Role of Rho GTPases in breast cancer. Front Biosci (2008) 1.39
Changes in Problem-Solving Capacity and Association With Spontaneous Brain Activity After a Single Electroconvulsive Treatment in Major Depressive Disorder. J ECT (2016) 1.39
Human pregnane X receptor and resistance to chemotherapy in prostate cancer. Cancer Res (2007) 1.35
K-bZIP of Kaposi's sarcoma-associated herpesvirus/human herpesvirus 8 (KSHV/HHV-8) binds KSHV/HHV-8 Rta and represses Rta-mediated transactivation. J Virol (2003) 1.32
14-3-3 interaction with histone H3 involves a dual modification pattern of phosphoacetylation. Mol Cell Biol (2008) 1.27
Correlation of serum VEGF levels with clinical stage, therapy efficacy, tumor metastasis and patient survival in ovarian cancer. Anticancer Res (2004) 1.24
Human UBN1 is an ortholog of yeast Hpc2p and has an essential role in the HIRA/ASF1a chromatin-remodeling pathway in senescent cells. Mol Cell Biol (2008) 1.23
Acupuncture for treating acute attacks of migraine: a randomized controlled trial. Headache (2009) 1.23
Paxillin binds schwannomin and regulates its density-dependent localization and effect on cell morphology. Nat Genet (2002) 1.22
G-protein-coupled receptor for short-chain fatty acids suppresses colon cancer. Int J Cancer (2010) 1.21
Activity-induced convergence of APP and BACE-1 in acidic microdomains via an endocytosis-dependent pathway. Neuron (2013) 1.21
The orthopoxvirus type I IFN binding protein is essential for virulence and an effective target for vaccination. J Exp Med (2008) 1.19
Site-specific introduction of an acetyl-lysine mimic into peptides and proteins by cysteine alkylation. J Am Chem Soc (2010) 1.15
CHK1 inhibitors in combination chemotherapy: thinking beyond the cell cycle. Mol Interv (2011) 1.14
Retracted Depression as a risk factor for dementia and mild cognitive impairment: a meta-analysis of longitudinal studies. Int J Geriatr Psychiatry (2012) 1.12
Enantioselective formal [3+3] annulation for the direct construction of bicyclic skeletons with four stereogenic centers. Org Lett (2007) 1.09
Switchable reactions of cyclopropanes with enol silyl ethers. Controllable synthesis of cyclopentanes and 1,6-dicarbonyl compounds. J Org Chem (2009) 1.09
Abnormal resting brain activity in patients with functional dyspepsia is related to symptom severity. Gastroenterology (2011) 1.08
[Anti-tumor activity and mechanism with SSCE of Spatholobus suberctus]. Zhongguo Zhong Yao Za Zhi (2009) 1.08
Cancer stem cells and resistance to chemo and radio therapy. Front Biosci (Elite Ed) (2012) 1.08
Mesothelin regulates growth and apoptosis in pancreatic cancer cells through p53-dependent and -independent signal pathway. J Exp Clin Cancer Res (2012) 1.08
Lapatinib and obatoclax kill breast cancer cells through reactive oxygen species-dependent endoplasmic reticulum stress. Mol Pharmacol (2012) 1.08
hCLCA2 Is a p53-Inducible Inhibitor of Breast Cancer Cell Proliferation. Cancer Res (2009) 1.08
Bispecific minibodies targeting HER2/neu and CD16 exhibit improved tumor lysis when placed in a divalent tumor antigen binding format. J Biol Chem (2004) 1.07
Applications of diffusion-weighted MRI in thoracic spinal cord injury without radiographic abnormality. Int Orthop (2006) 1.07
A novel chiral sulfonium yilde: highly enantioselective synthesis of vinylcyclopropanes. J Am Chem Soc (2002) 1.05
Oxidative stress, inflammation, and autophagic stress as the key mechanisms of premature age-related hearing loss in SAMP8 mouse Cochlea. Antioxid Redox Signal (2011) 1.05
Effects of two Lactobacillus strains on lipid metabolism and intestinal microflora in rats fed a high-cholesterol diet. BMC Complement Altern Med (2011) 1.02
Downregulation of vascular endothelial growth factor and induction of tumor dormancy by 15-lipoxygenase-2 in prostate cancer. Int J Cancer (2009) 1.02
PPAR gamma, bioactive lipids, and cancer progression. Front Biosci (Landmark Ed) (2012) 1.01
Thromboxane A2 receptors in prostate carcinoma: expression and its role in regulating cell motility via small GTPase Rho. Cancer Res (2008) 1.01
Human CABIN1 is a functional member of the human HIRA/UBN1/ASF1a histone H3.3 chaperone complex. Mol Cell Biol (2011) 1.00
Hepatitis C virus NS3 helicase forms oligomeric structures that exhibit optimal DNA unwinding activity in vitro. J Biol Chem (2008) 1.00
A review of acupoint specificity research in china: status quo and prospects. Evid Based Complement Alternat Med (2012) 1.00
Estimation of the number of nerve fibers in the human vestibular endorgans using unbiased stereology and immunohistochemistry. J Neurosci Methods (2005) 0.99
Non-steroid anti-inflammatory drugs, prostaglandins, and cancer. Cell Biosci (2013) 0.99
Platelet-type 12-lipoxygenase activates NF-kappaB in prostate cancer cells. Prostaglandins Other Lipid Mediat (2003) 0.98
Impairment of mitochondrial respiration in mouse fibroblasts by oncogenic H-RAS(Q61L). Cancer Biol Ther (2010) 0.98
Randomized controlled trial to treat migraine with acupuncture: design and protocol. Trials (2008) 0.98
Transcriptional profiles of bovine in vivo pre-implantation development. BMC Genomics (2014) 0.97
Regional estimates of hair cells and supporting cells in the human crista ampullaris. J Neurosci Res (2005) 0.97
Influence of acupuncture treatment on cerebral activity in functional dyspepsia patients and its relationship with efficacy. Am J Gastroenterol (2012) 0.97
Transition state studies on the dioxirane-mediated asymmetric epoxidation via kinetic resolution and desymmetrization. J Org Chem (2005) 0.96
The Skap-hom dimerization and PH domains comprise a 3'-phosphoinositide-gated molecular switch. Mol Cell (2008) 0.96
Reduced immunomodulation potential of bone marrow-derived mesenchymal stem cells induced CCR4+CCR6+ Th/Treg cell subset imbalance in ankylosing spondylitis. Arthritis Res Ther (2011) 0.96
Overlapping and distinct pRb pathways in the mammalian auditory and vestibular organs. Cell Cycle (2011) 0.95
Asymmetric Nazarov reaction catalyzed by chiral tris(oxazoline)/copper(II). Angew Chem Int Ed Engl (2010) 0.95
Sidearm effect: improvement of the enantiomeric excess in the asymmetric Michael addition of indoles to alkylidene malonates. J Am Chem Soc (2002) 0.94
[Thinking about building a clinical syndrome differentiation system of acupuncture and moxibustion]. Zhongguo Zhen Jiu (2008) 0.93
Ultrasound-targeted microbubble destruction mediated herpes simplex virus-thymidine kinase gene treats hepatoma in mice. J Exp Clin Cancer Res (2010) 0.93
An integrated approach utilizing proteomics and bioinformatics to detect ovarian cancer. J Zhejiang Univ Sci B (2005) 0.93
Case-based learning in education of Traditional Chinese Medicine: a systematic review. J Tradit Chin Med (2013) 0.93
12-Lipoxygenase and the regulation of hypoxia-inducible factor in prostate cancer cells. Exp Cell Res (2010) 0.93
Structurally related cytotoxic effects of flavonoids on human cancer cells in vitro. Arch Pharm Res (2008) 0.92
Enriched environment increases the myelinated nerve fibers of aged rat corpus callosum. Anat Rec (Hoboken) (2012) 0.92
Growing trend of China's contribution to the field of spine: a 10-year survey of the literature. Eur Spine J (2015) 0.92
Regulation of drug resistance by human pregnane X receptor in breast cancer. Cancer Biol Ther (2009) 0.91
1H NMR-based metabonomic study on the metabolic changes in the plasma of patients with functional dyspepsia and the effect of acupuncture. J Pharm Biomed Anal (2009) 0.91
Berberine and total base from rhizoma coptis chinensis attenuate brain injury in an aluminum-induced rat model of neurodegenerative disease. Saudi Med J (2009) 0.90
The role of short-chain fatty acids in orchestrating two types of programmed cell death in colon cancer. Autophagy (2011) 0.90
Pregnane X receptor and its potential role in drug resistance in cancer treatment. Recent Pat Anticancer Drug Discov (2009) 0.90
Iron porphyrin-catalyzed olefination of ketenes with diazoacetate for the enantioselective synthesis of allenes. J Am Chem Soc (2007) 0.89
Camptothecin attenuates cytochrome P450 3A4 induction by blocking the activation of human pregnane X receptor. J Pharmacol Exp Ther (2010) 0.89
A simple photoactivation and image analysis module for visualizing and analyzing axonal transport with high temporal resolution. Nat Protoc (2011) 0.89
BRCA1 overexpression sensitizes cancer cells to lovastatin via regulation of cyclin D1-CDK4-p21WAF1/CIP1 pathway: analyses using a breast cancer cell line and tumoral xenograft model. Int J Oncol (2008) 0.88
Acupuncture as a treatment for functional dyspepsia: design and methods of a randomized controlled trial. Trials (2009) 0.88
Strong neutral spatial effects shape tree species distributions across life stages at multiple scales. PLoS One (2012) 0.88
Growth factors in tumor microenvironment. Front Biosci (Landmark Ed) (2010) 0.88
Cancer stem cells and niche mircoenvironments. Front Biosci (Elite Ed) (2012) 0.87
Brain areas involved in acupuncture treatment on functional dyspepsia patients: a PET-CT study. Neurosci Lett (2009) 0.87
Dietary taurine supplementation ameliorates diabetic retinopathy via anti-excitotoxicity of glutamate in streptozotocin-induced Sprague-Dawley rats. Neurochem Res (2007) 0.86
Chaperone-mediated acetylation of histones by Rtt109 identified by quantitative proteomics. J Proteomics (2012) 0.86
Enantioselective Friedel-Crafts reaction of indoles with arylidene malonates catalyzed by iPr-bisoxazoline-Cu(OTf)2. Chem Commun (Camb) (2004) 0.86
The Michael addition-elimination of ylides to alpha,beta-unsaturated imines. Highly stereoselective synthesis of vinylcyclopropanecarbaldehydes and vinylcyclopropylaziridines. J Am Chem Soc (2005) 0.86
[Specificity of acupoint effects and its fundamental laws]. Zhongguo Zhen Jiu (2009) 0.86
Sorafenib enhances pemetrexed cytotoxicity through an autophagy-dependent mechanism in cancer cells. Autophagy (2011) 0.86
Trisoxazoline/Cu(II)-promoted Kinugasa reaction. Enantioselective synthesis of beta-lactams. J Org Chem (2006) 0.86
Effects and safety of allogenic mesenchymal stem cell intravenous infusion in active ankylosing spondylitis patients who failed NSAIDs: a 20-week clinical trial. Cell Transplant (2013) 0.85